Overview

Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and Plasma

Status:
Unknown status
Trial end date:
2011-03-01
Target enrollment:
0
Participant gender:
Male
Summary
The impact of anti-platelet drugs on the concentrations of Brain-derived neurotrophic factor (BDNF) in human plasma and serum is unknown. It is the aim of this study to investigate the impact of a single dose of Aspirin (500 mg) or Clopdigrel (600 mg) on the concentrations of Brain-derived neurotrophic factor (BDNF) in plasma and serum of healthy volunteers.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Rostock
Treatments:
Aspirin
Clopidogrel
Ticlopidine
Criteria
Inclusion Criteria:

- Age 18-50 years

- Gender: Male

Exclusion Criteria:

- Any acute disease

- Any chronic disease

- Any medication

- Allergies / Intolerance in association with Aspirin or Clopidogrel